(1) Approval for opening of the hospital
| Approval for opening of the hospital under the Medical Service Act | November 1, 1921 | |
|---|---|---|
(2) Advanced treatment hospital
| Approval date | October 1, 1994 | |
|---|---|---|
(3) Status of facility standards established by the Minister of Health, Labour and Welfare
Basic Medical Fees (198.4KB)- Special Medical Fees (211.1KB)
(4) Expenses for meals during hospitalization
| Expenses for meals during hospitalization (I), Expenses for daily living care during hospitalization (I) | December 14, 1970 | |
|---|---|---|
(5) Certification as an organ transplant facility
| Organ | Certified date | |
|---|---|---|
| Kidney | September 12, 1995 | |
| Pancreas | February 15, 1999 | |
| Small intestine | December 24, 1999 | |
| Liver | May 22, 2000 | |
| Heart | July 5, 2010 | |
(6) Designation as a core hospital (certification)
| Designation (certification) title | Designated (certified) date | |
|---|---|---|
| AIDS core hospital | August 1, 1996 | |
| Disaster base hospital (regional disaster medical center) | April 1, 2002 | |
| Cancer core hospital | April 1, 2009 | |
| Liver disease core hospital | August 24, 2009 | |
| Pediatric cancer core hospital | February 8, 2013 | |
(7) Certified advanced medical care
| Advanced medical care | Certified date | |
|---|---|---|
| Minimal invasive vertebral disk curettage and cleaning method (advanced medical care) | July 1, 2011 | |
| Combination therapy of post-surgery hormonal therapy and administration of S-1 for primary breast cancer (limited to when estrogen receptor is positive and HER2 is negative) | June 1, 2012 | |
| Transplacental antiarrhythmic drug therapy for fetal tachycardiac arrhythmia (limited to auricular flutter or supraventricular tachycardia when the fetal heart rate is 180/min. or higher) | January 1, 2013 | |
| Proton therapy | August 1, 2014 | |
| Octreotide hypodermic injection therapy for congenital hyperinsulinemia (limited to when the patient is at a week or older and under 12 months and when the oral administration of diazoxide is not effective) | August 1, 2014 | |
| Diagnosis of recurrent head and neck tumor by positron computerized tomography using 11C-labeled methionine if suspected (limited to primary or metastatic brain tumors (limited to patients who had received radiotherapy longer than half a year before) or tumor of the epipharynx, cranial bone or other organs near the brain (limited to patients who had received radiotherapy longer than half a year before) | December 1, 2014 | |
| Combination therapy of the administration of temozolomide after massive methotrexate dose therapy before irradiation or radiotherapy, and temozolomide maintenance therapy for new-onset primary central nervous system lymphoma (limited to when it is pathologically diagnosed as diffuse large B-cell lymphoma, and the primary site is the cerebrum, cerebellum or brainstem) | January 1, 2006 | |
| Recurrence-inhibition therapy by perioperative intravenous carperitide administration for non-small cell lung cancer (excluding non-invasive cancer diagnosed by CT imaging) | February 1, 2016 | |
| Diagnosis by positron computerized tomography using 11C-labeled methionine for suspected primary glioma (limited to when the patient is scheduled to undergo biopsy or surgery) | April 1, 2016 | |
| Internal radiation therapy using 131 I-MIBG for intractable pheochromocytoma (including paraganglioma) | June 1, 2016 | |
| Proton therapy for hepatoma (limited to primary hepatoma that is difficult to cure by hepatectomy, hepatic transplantation, local injection of ethanol, microwave coagulation therapy or radiofrequency ablation, and the Child Pugh score is less than seven) | June 1, 2016 | |
Adobe Reader is necessary to see the PDF file.
If you do not have Adobe Reader, click the “Get Adobe Reader” icon on the left.
If you do not have Adobe Reader, click the “Get Adobe Reader” icon on the left.
